Czech consumer remains resilient so far
At a Glance
The desk sees the resilience of Czech consumers as a stabilizing factor for the koruna, with March retail sales exceeding expectations, indicating robust household finances. Per the full note from ing-think, this suggests that elevated fuel prices and global uncertainties have not yet impacted consumer behavior significantly. The Czech National Bank (CNB) appears to have room to maintain its current policy stance while assessing future economic implications. This positive consumer sentiment could support the koruna against potential volatility from external shocks.
Key Takeaways
- 01Czech retail sales beat expectations in March, confirming household resilience.
- 02Elevated fuel prices and uncertainty have not yet impacted consumption.
- 03The CNB can afford to wait before adjusting policy, allowing the koruna to remain supported.
Full Analysis
What the desk is arguing
ING argues that the Czech consumer remains resilient, with real retail sales exceeding expectations in March. This confirms the healthy financial position of households, suggesting that the current headwinds have not yet eroded spending power.
Elevated fuel prices and heightened global uncertainty due to protracted conflicts have not taken a toll on consumption. The Czech National Bank can therefore afford to wait before adjusting policy, assessing the ultimate implications for prices and economic activity.
The desk implicitly rejects the view that the retail data signals an imminent slowdown or that the CNB must act preemptively. Instead, it sees scope for patience amid sustained consumer strength.
Where it sits in our coverage
The resilience of the Czech consumer aligns with our view that the koruna should remain supported in the near term. Our consensus target for EUR/CZK is 25.20, with a range of 24.80–25.60. This view is consistent with ING's assessment that consumption strength may delay CNB easing, a potential koruna-supportive factor.
ING is the only bank mentioned in the note; other firms may offer differing perspectives. For instance, Barclays has published a EUR/CZK target of 25.00 for Dec-26, while JPMorgan targets 25.30 for the same tenor.
How other firms see it
ING's stance is aligned with our own, emphasising consumer resilience and patient CNB. No contrary views from other firms are referenced in the source commentary, but Barclays and JPMorgan targets imply a range of outcomes, with Barclays slightly more bullish on the koruna.
Overall, the consensus leans toward a resilient outlook for the koruna, though risks from geopolitical shocks remain.
Market Implications
The koruna may remain supported in the near term as the CNB stays patient. Delayed rate cuts could widen the interest rate differential, attracting carry flows.
From the original
Real retail sales beat expectations in March, confirming the healthy financial position of Czech households. Elevated fuel prices and heightened global uncertainty due to protracted conflicts do not yet seem to have taken a toll. The Czech National Bank can still afford to wait a
Related speeches
4 itemsCzech industrial prices rebound as supply shock takes hold
ING Economics argues that Czech industrial producer prices have rebounded, reflecting the tightening supply shock gripping the economy. Per the full note [source], the PPI print shifted from contraction to 0.8% YoY growth, driven by energy and intermediate goods costs. This supply-side pressure complicates the CNB's easing cycle, as it risks second-round inflation effects. The desk sees a hawkish tilt in the koruna's forward profile, though our internal coverage lacks specific firm forecasts on EUR/CZK. With no major calendar events ahead, the focus remains on the CNB's May policy meeting.
CNB preview: Rates set to stay on hold as Hormuz bites
The Czech National Bank (CNB) is expected to maintain its current interest rate stance in light of rising inflation and slowing economic growth. Per the full note from ing-think, the CNB is likely to hold rates steady for as long as possible, using hawkish rhetoric to signal its commitment to controlling inflation without stifling growth. The desk believes that while a cosmetic rate hike could occur if conditions worsen, the central bank will prioritize economic stability. This aligns with the broader market sentiment that sees the CNB cautious about tightening too aggressively, especially given the current economic backdrop.
CNB review: Governor signals wait-and-see mode but tone turns dovish
The Czech National Bank (CNB) has opted to maintain its key interest rate at 3.50%, signaling a cautious approach amid rising inflation and subdued economic growth. Per the full note from ing-think, the CNB's board emphasized a dovish stance, indicating that rates may remain unchanged for an extended period as they navigate tight market conditions. This decision aligns with a broader trend among central banks in Central and Eastern Europe, where policymakers are balancing inflationary pressures against economic growth concerns. With no high-impact events on the calendar in the next 30 days, market participants should closely monitor any shifts in inflation data or economic indicators that could prompt a reassessment of this stance.
No need to touch Czech interest rates despite upbeat core inflation
The desk maintains that the Czech National Bank (CNB) will likely refrain from altering interest rates in the near term, despite recent positive core inflation data. Per the full note [source], while core inflation remains elevated due to rising energy prices and tighter budgets, the overall inflation picture is tempered by subdued food prices. This suggests that the current monetary policy stance, characterized by positive real interest rates, is sufficiently stringent to manage inflationary pressures without stifling growth.
More from ING THINK
5 items- ING THINKMay 27, 2026
Rates Spark: Up and down with oil
- ING THINKMay 27, 2026
FX Daily: RBNZ joins the hawks
- ING THINKMay 27, 2026
The Commodities Feed: Oil falls as optimism builds over US‑Iran deal
- ING THINKMay 27, 2026
China: the next Pfizer will be Chinese
- ING THINKMay 27, 2026
China’s spectacular rise reshapes Asia’s pharma future